Supportive and Preventive Medicine
Patient Cases
A 93-year-old man (weight 45 kg) confined to his bed is admitted from a nursing home with a chronic
obstructive pulmonary disease exacerbation requiring mechanical ventilation. He has a history of diabetes
and heart failure. His laboratory values are all within normal limits except for BUN 35 mg/dL and SCr 2.8
mg/dL (baseline 0.5). Which would be the most appropriate recommendation for VTE prophylaxis in this
patient?
Questions 6 and 7 pertain to the following case.
A 55-year-old man (weight 60 kg) with a medical history of diabetes, hyperlipidemia, and a DVT 4 months ago
secondary to lower-extremity trauma is admitted today to the ICU for acute respiratory failure from influenza
virus. His current laboratory values are as follows: WBC 13.1 x 103 cells/mm3, Plt 250,000/mm3, BUN 13 mg/dL,
SCr 0.9 mg/dL, INR 1.2, AST 22 IU/mL, and ALT 11 IU/mL. His current medication regimen includes fentanyl
and midazolam boluses for pain and agitation, piperacillin/tazobactam, vancomycin, regular insulin infusion, SUP,
and a heparin drip. Five days later, the patient remains intubated on the same medications. At this time, his Plt
has decreased to 112,000/mm3, and his BUN and SCr have increased to 45 mg/dL and 2.7 mg/dL, respectively.
The team sends a heparin-PF4 immunoassay; however, the results will not return for 48 hours.
Which would be the best course of action?
Three days later, both the heparin-PF4 immunoassay and the serotonin release assay return positive, and the
patient has a new DVT. The team wants to initiate warfarin. The patientβs current Plt is 130,000/mm3. Which
would be the most appropriate response?
of patients and their families facing the problems associated with life-threatening illness, through the
prevention and relief of suffering by means of early identification and impeccable assessment and treatment
of pain and other problems, physical, psychosocial, and spiritualβ (Global Atlas of Palliative Care at the End
of Life).